Evidence map›Paper›PMID 39022414›Full record

ArticleFrontiers in public health2024

Reviving health mediation during the COVID-19 crisis and beyond: an implementation study in deprived neighbourhoods of Marseille, France.

Alix Fruleux, Jean Gaudart, Florian Franke, Steve Nauleau, Anne Dutrey Kaiser, Eva Legendre, Dorothée Balma, Marc Lescaudron, Lucile Tamalet, Philippe Malfait and 2 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alix FruleuxVille de Marseille, Direction de la Santé publique et de l'Inclusion, Marseille, France.
Jean GaudartAix-Marseille Université, Inserm, IRD, UMR1252 SESSTIM, ISSPAM, Marseille, France.
Florian FrankeSanté publique France, Marseille, France.
Steve NauleauAgence régionale de santé Provence-Alpes-Côte d'Azur (ARS Paca), Marseille, France.
Anne Dutrey KaiserProspective & Coopération, Marseille, France.
Eva LegendreHôpital Européen, Marseille, France.
Dorothée BalmaHôpital Européen, Marseille, France.
Marc LescaudronProspective & Coopération, Marseille, France.
Lucile TamaletHôpital Européen, Marseille, France.
Philippe MalfaitSanté publique France, Marseille, France.
Pascal ChaudSanté publique France, Marseille, France.
Stanislas RebaudetAix-Marseille Université, Inserm, IRD, UMR1252 SESSTIM, ISSPAM, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In 2020, during France's COVID-19 response, healthcare professionals from a hospital and an association initiated health mediation interventions in Marseille's vulnerable neighbourhoods, funded by the regional health authorities. This mixed method research evaluates the CORHESAN program that lasted until June 2022. Methods: We examined CORHESAN documents and reports, conducted interviews, and analysed activity data, comparing it to the COVID-19 hotspots identified on a weekly basis at the neighbourhood level, using generalised linear mixed models (GLMMs). Results: CORHESAN was implemented by a team of up to nine health mediators, six private nurses hired on an Discussion: The pandemic emphasised the potential of health mediation interventions to address health disparities. Building on this, a new program began in July 2022, aiming at enhancing cancer screening and vaccinations in deprived areas of Marseille. Evaluations are ongoing to assess its activities and impact, and provide evidence to future implementation initiatives.

Indexed as

COVID-19Residence CharacteristicsAdultFemaleFranceHumansMaleMiddle AgedPoverty AreasSARS-CoV-2community outreachCOVID-19disease hotspothealth education and awarenesshealth mediationimplementation sciencetestingvaccination

Identifiers

PMID39022414
PMCPMC11251881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.